RevitalVision Demonstrates Efficacy and Safety in Infantile Nystagmus Treatment

RevitalVision announces positive clinical data for its digital therapeutic treatment for infantile nystagmus, showing statistically significant improvements in visual function. The study, published in the British Journal of Ophthalmology, demonstrates that the neuroplasticity-based visual training program can effectively enhance visual acuity, contrast sensitivity, and functional vision in affected patients.